| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/28/1999 | EP0911035A2 Insoluble insulin compositions |
| 04/28/1999 | EP0911033A2 Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 04/28/1999 | EP0910669A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof |
| 04/28/1999 | EP0910662A1 Methods and reagents for typing hla class i genes |
| 04/28/1999 | EP0910659A2 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 04/28/1999 | EP0910658A1 Protein expression system |
| 04/28/1999 | EP0910657A1 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
| 04/28/1999 | EP0910656A1 Virus-like particles useful as a vector for delivering nucleic acid |
| 04/28/1999 | EP0910655A1 Vaccines for treatment of lymphoma and leukemia |
| 04/28/1999 | EP0910652A1 Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto |
| 04/28/1999 | EP0910650A1 Transgenic plants expressing rabies glycoprotein g, and glycoproteins thus obtained |
| 04/28/1999 | EP0910648A1 Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods |
| 04/28/1999 | EP0910646A1 Brain glycogen phosphorylase cancer antigen |
| 04/28/1999 | EP0910643A1 Ribonuclease resistant rna preparation and utilization |
| 04/28/1999 | EP0910642A1 A method for increasing hemoprotein production in filamentous fungi |
| 04/28/1999 | EP0910641A1 Neural cell adhesion molecule splicing variants |
| 04/28/1999 | EP0910640A2 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization |
| 04/28/1999 | EP0910639A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG |
| 04/28/1999 | EP0910638A2 Polynucleotide encoding secreted proteins |
| 04/28/1999 | EP0910637A1 Polynucleotide encoding secreted protein isolated from human dendritic cells |
| 04/28/1999 | EP0910636A1 Human b-cell antigens, related reagents |
| 04/28/1999 | EP0910635A1 Hematopoietic cytokine receptor |
| 04/28/1999 | EP0910628A1 Inactivation resistant factor viii |
| 04/28/1999 | EP0910623A1 Thrombin receptor modified transgenic animals |
| 04/28/1999 | EP0910583A1 Thrombin inhibitors |
| 04/28/1999 | EP0910582A1 Cell adhesion inhibiting compounds |
| 04/28/1999 | EP0910581A1 Method for the affinity-chromatographic purification of factor viii |
| 04/28/1999 | EP0910580A1 Modified factor vii |
| 04/28/1999 | EP0910579A1 Compounds with growth hormone releasing properties |
| 04/28/1999 | EP0910578A2 Recombinant expression of proteins from secretory cell lines |
| 04/28/1999 | EP0910577A2 Hypertonia gene |
| 04/28/1999 | EP0910576A2 Fusogenic liposomes |
| 04/28/1999 | EP0910574A2 Method for discovering novel anthelmintic compounds |
| 04/28/1999 | EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 04/28/1999 | EP0910413A2 TREATMENT OF ASTHMA WITH TNFR-Ig |
| 04/28/1999 | EP0910409A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 04/28/1999 | EP0910406A1 Recombinant canine herpesviruses |
| 04/28/1999 | EP0910405A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 04/28/1999 | EP0910404A1 A vaccine composition comprising helicobacter pylori flagellin polypeptide |
| 04/28/1999 | EP0910403A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof |
| 04/28/1999 | EP0910401A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
| 04/28/1999 | EP0910400A1 Therapies for chronic renal failure |
| 04/28/1999 | EP0910396A1 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof |
| 04/28/1999 | EP0910387A1 Apoptosis associated protein bbk |
| 04/28/1999 | EP0910243A2 Il-5 transgenic mouse |
| 04/28/1999 | EP0876509A4 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 04/28/1999 | EP0789705A4 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy |
| 04/28/1999 | EP0753010A4 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
| 04/28/1999 | EP0723555A4 Chimeric proteins which block complement activation |
| 04/28/1999 | EP0679092B1 Cytokine restraining agents |
| 04/28/1999 | EP0658119B1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate |
| 04/28/1999 | EP0647232B1 Deproteinization with azlactone-functional supports |
| 04/28/1999 | EP0625991B1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes |
| 04/28/1999 | EP0592480B1 Use of papillomavirus L2 protein for therapeutic treatment of papillomavirus tumours or lesions |
| 04/28/1999 | EP0494268B2 Method for inhibiting growth of stem cells |
| 04/28/1999 | EP0456766B1 TYPE oc PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE |
| 04/28/1999 | CN1215432A Hormone-mediated methods for modulating expression of exogenous genes in mammlian system, and products related thereto |
| 04/28/1999 | CN1215431A Genomic nucleic acids, cDNA and mDNA which code for polypeptides with IL-16 activity, processes for the production thereof and their use |
| 04/28/1999 | CN1215430A Intracellular antifreeze polypeptides and nucleic acids |
| 04/28/1999 | CN1215405A Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| 04/28/1999 | CN1215404A Non-dendritic backbone piptide carrier |
| 04/27/1999 | US5898792 Methods and devices for automatic assessment of corn |
| 04/27/1999 | US5898097 Transgenic plants comprising nucleotide sequences encoding dysfunctional viral movement protein (dmp) genes. |
| 04/27/1999 | US5898096 Plant promoter |
| 04/27/1999 | US5898094 Rodent models displaying enhanced alzheimer's disease phenotypic and physiological characteristics; produced by breeding modified rodents and comparing mutant offspring to nonmutant rodents |
| 04/27/1999 | US5898069 Phosphate-binding protein containing (i) an inorganic phosphate ion binding site and (ii) a detectable label that produces a signal whose amplitude changes detectably upon the binding of inorganic phosphate ion to the binding site |
| 04/27/1999 | US5898067 Crystallization of proteins |
| 04/27/1999 | US5898066 Trophic factors for central nervous system regeneration |
| 04/27/1999 | US5898030 hGH containing pharmaceutical compositions |
| 04/27/1999 | US5897867 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens |
| 04/27/1999 | US5897862 Immuno-stimulatory monoclonal antibodies |
| 04/27/1999 | CA2248119A1 Novel apt |
| 04/27/1999 | CA2248116A1 Novel muty |
| 04/27/1999 | CA2243874A1 Antibody recognizing body fluid cell surface antigen |
| 04/27/1999 | CA2107329C Anti-human immunodeficiency virus recombinant antibodies |
| 04/27/1999 | CA2083826C Protein having cytokine type activity, recombinant dna coding for this protein, transformed cells and microorganisms |
| 04/27/1999 | CA2064585C Inhibition of tumor growth by blockade of the protein c system |
| 04/27/1999 | CA2000345C Production of hydrolysed proteins |
| 04/27/1999 | CA1340512C Expression of factor vii and ix activities in mammalian cells |
| 04/24/1999 | CA2248170A1 A clone hwhhj20 |
| 04/24/1999 | CA2219299A1 P-40, a new member of the multidrug resistance gene family |
| 04/23/1999 | CA2245997A1 Novel compounds |
| 04/23/1999 | CA2239255A1 Cdna clone hneaa81 that encodes a human 7-transmembrane receptor |
| 04/22/1999 | WO1999019732A1 Methods and compositions for detecting hepatitis e virus |
| 04/22/1999 | WO1999019513A2 Methods for detecting compounds which modulate the activity of an lpa receptor |
| 04/22/1999 | WO1999019506A2 Method for identifying binding ligands to receptors |
| 04/22/1999 | WO1999019501A1 Non-integrating dna vector of retroviral origin having high-protein expression, and secreted immunogenic antigens |
| 04/22/1999 | WO1999019492A2 Methods for obtaining plant varieties |
| 04/22/1999 | WO1999019491A2 Human dnax interleukin-40 (dil-40) |
| 04/22/1999 | WO1999019490A1 Apo-3 ligand |
| 04/22/1999 | WO1999019489A1 MYOSIN IXa AND CYCLIC NUCLEOTIDE GATED CHANNEL-15 (CNGC-15) POLYNUCLEOTIDES, POLYPEPTIDES, COMPOSITIONS, METHODS AND USES THEREOF |
| 04/22/1999 | WO1999019488A1 Novel human egf receptors and use thereof |
| 04/22/1999 | WO1999019487A1 Mammoglobin homolog |
| 04/22/1999 | WO1999019486A1 Cell division regulators |
| 04/22/1999 | WO1999019485A1 THYMOSIN β15 PROMOTER AND USE THEREOF |
| 04/22/1999 | WO1999019484A1 T cell receptor-associated molecules (trams) and methods of use therefor |
| 04/22/1999 | WO1999019483A1 Human progesterone receptor complex p23-like protein |
| 04/22/1999 | WO1999019482A2 Vesicle transport associated proteins |
| 04/22/1999 | WO1999019481A2 Mammalian genes involved in viral infection and tumor suppression |
| 04/22/1999 | WO1999019480A2 Human receptor proteins; related reagents and methods |